The PCSK9i Inhibitor Evolocumab – a Surgical Trial of Pharamcodynamics and Kinetics Evaluation
Condition(s):Malignant Glioma; GlioblastomaLast Updated:October 26, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Malignant Glioma; GlioblastomaLast Updated:October 26, 2023Recruiting
Condition(s):ST-elevation Myocardial InfarctionLast Updated:April 26, 2021Withdrawn
Condition(s):Human Immunodeficiency Virus; Coronary Artery DiseaseLast Updated:July 24, 2020Completed
Condition(s):Type 2 Diabetes MellitusLast Updated:November 3, 2021Completed
Condition(s):Clinical Trial; Acute Coronary SyndromeLast Updated:October 5, 2023Recruiting
Condition(s):Homozygous Familial Hypercholesterolemia HoFHLast Updated:November 27, 2020Completed
Condition(s):Cardiac Allograft VasculopathyLast Updated:November 1, 2023Completed
Condition(s):Hypercholesterolemia; ASCVD; PregnancyLast Updated:December 17, 2020Terminated
Condition(s):Carotid Artery DiseaseLast Updated:July 28, 2021Unknown status
Condition(s):Heart Failure With Reduced Ejection FractionLast Updated:February 15, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.